| topiramate / Generic mfg. |
NCT00231530: A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet |
|
|
| Completed | 3 | 541 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset | | 05/02 | | |
NCT00236639: A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity |
|
|
| Completed | 3 | 1293 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity | | 06/02 | | |
NCT00236600: A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program |
|
|
| Completed | 3 | 561 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity | | 06/02 | | |
NCT00231660: A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin |
|
|
| Completed | 3 | 211 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset | | 06/02 | | |
NCT00231621: A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia |
|
|
| Terminated | 3 | 179 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity, Hyperlipidemia, Hypertriglyceridemia | | 06/02 | | |
NCT00231634: A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy |
|
|
| Terminated | 3 | 31 | US | topiramate | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset | | 11/02 | | |
